Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.
about
Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Vernakalant is superior to ibu ...... l at the emergency department.
@ast
Vernakalant is superior to ibu ...... l at the emergency department.
@en
Vernakalant is superior to ibu ...... l at the emergency department.
@nl
type
label
Vernakalant is superior to ibu ...... l at the emergency department.
@ast
Vernakalant is superior to ibu ...... l at the emergency department.
@en
Vernakalant is superior to ibu ...... l at the emergency department.
@nl
prefLabel
Vernakalant is superior to ibu ...... l at the emergency department.
@ast
Vernakalant is superior to ibu ...... l at the emergency department.
@en
Vernakalant is superior to ibu ...... l at the emergency department.
@nl
P2093
P2860
P356
P1433
P1476
Vernakalant is superior to ibu ...... l at the emergency department.
@en
P2093
Alexander O Spiel
Alexander Simon
Anton N Laggner
Ekaterini Skyllouriotis
Hans Domanovits
Harald Herkner
Jan Niederdoeckl
Nikola Schuetz
P2860
P304
P356
10.1093/EUROPACE/EUW052
P577
2017-02-01T00:00:00Z